TY - JOUR
AU - M. M. Kanervo
AU - S. J. Tupola
AU - E. M. Nikkola
AU - K. M. Rantakari
AU - H. K. Kahila
A1 - 
AD - Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Doctoral Program in Clinical Research, University of Helsinki, Helsinki, Finland.; Gynecology and Obstetrics, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
AN - 36562462
BT - Acta Obstet Gynecol Scand
C5 - Opioids & Substance Use; Healthcare Disparities; Measures
CP - 3
DA - Mar
DO - 10.1111/aogs.14497
DP - NLM
ET - 20221223
IS - 3
JF - Acta Obstet Gynecol Scand
LA - eng
PY - 2023
SN - 0001-6349 (Print); 0001-6349
SP - 313
EP - 322+
ST - Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
T1 - Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
T2 - Acta Obstet Gynecol Scand
TI - Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
U1 - Opioids & Substance Use; Healthcare Disparities; Measures
U3 - 10.1111/aogs.14497
VL - 102
VO - 0001-6349 (Print); 0001-6349
Y1 - 2023
ER -